EU OKs Dune's next-gen breast cancer tissue assessment device

02/20/2013 | Boston Herald

Dune Medical Devices has obtained approval in Europe to market a next-generation version of its MarginProbe System console, a device used for intra-operative tissue evaluation during early-stage breast cancer procedures. The MarginProbe System Type 1.2 improves on the original model with a more compact size, better aesthetics and enhanced overall design.

View Full Article in:

Boston Herald

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC